2017
DOI: 10.1530/joe-17-0185
|View full text |Cite
|
Sign up to set email alerts
|

Treating the dysfunctional placenta

Abstract: Placental dysfunction underlies major obstetric diseases such as pre-eclampsia and fetal growth restriction (FGR). Whilst there has been a little progress in prophylaxis, there are still no treatments for placental dysfunction in normal obstetric practice. However, a combination of increasingly well-described in vitro systems for studying the human placenta, together with the availability of more appropriate animal models of pre-eclampsia and FGR, has facilitated a recent surge in work aimed at repurposing dru… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
36
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(38 citation statements)
references
References 89 publications
0
36
0
2
Order By: Relevance
“…IPA of our data revealed that more than 50 pathways were disrupted in the first-trimester placenta derived from IVF-ET. Further analysis showed that these pathways are widely involved in key events of early placental development and function, whose disruption can lead to adverse outcomes [47][48][49]. We report the enrichment of multiple genes in the top 50 significantly overrepresented biological pathways.…”
Section: Discussionmentioning
confidence: 75%
“…IPA of our data revealed that more than 50 pathways were disrupted in the first-trimester placenta derived from IVF-ET. Further analysis showed that these pathways are widely involved in key events of early placental development and function, whose disruption can lead to adverse outcomes [47][48][49]. We report the enrichment of multiple genes in the top 50 significantly overrepresented biological pathways.…”
Section: Discussionmentioning
confidence: 75%
“…Recently, accumulating evidence suggested that placental dysfunction underlies major obstetric diseases such as pre-eclampsia and FGR [ 23 ]. EVT, a subset of placental cells, plays a critical role in this process.…”
Section: Discussionmentioning
confidence: 99%
“…Screening of first trimester endocrine constitution of the maternal circulation for traces of unbalanced parental antagonism is showing more promising progress [ 6 ]. Few new therapies are being developed, but we are curiously awaiting the results of the EVERREST-trial in which the effects of genetherapy of the placenta are investigated [ 7 ].…”
Section: Future Implicationsmentioning
confidence: 99%